 |
| PDB ID: 1wyy Macromolecule: E2 GLYCOPROTEIN Source Organism: SARSr Gene names: - UniProt ID: P59594 |
SIMILAR PATTERN OF AMINO ACIDS MAPPED TO PDBID '1wyy'
1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.| DrReposER ID / Desc. | Drug | Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RLB_E_REAE176_1 (RETINOL BINDINGPROTEIN) | Tretinoin | 5 / 10 | ALA A 926LEU B 930GLN B 931ASP A1165GLN A 931 | 1.56A | 22.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BWY_A_SAMA301_1 (COMT PROTEIN) | S-Adenosylmethionine | 3 / 3 | SER B 924GLU B 918ASP A 932 | 1.18A | 22.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TLM_A_MILA128_1 (TRANSTHYRETIN) | Milrinone | 3 / 3 | LEU B1167LEU B 920SER B 919 | 0.80A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_A_KANA301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.14A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVT_A_FLPA125_1 (TRANSTHYRETIN) | Flurbiprofen | 5 / 8 | LEU A1174LEU A 920LEU A 930LEU A 927SER A 924 | 1.57A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QTU_D_SAMD301_1 (PUTATIVEMETHYLTRANSFERASEBUD23) | S-Adenosylmethionine | 4 / 5 | GLN B 947LEU B 948SER B 949ASP B 961 | 1.26A | 20.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5K7U_A_SAMA601_1 (N6-ADENOSINE-METHYLTRANSFERASE 70 KDASUBUNIT) | S-Adenosylmethionine | 3 / 3 | ASP A 932ASN B1175GLN B 917 | 1.60A | 20.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_F_SVRF502_3 (PHOSPHOLIPASE A2) | Suramin | 5 / 12 | LEU A1147GLY A1148ILE A1150SER A 949SER A 950 | 1.41A | 20.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7P_A_SALA1000_1 (LYSR-TYPE REGULATORYPROTEIN) | Salicylic acid | 5 / 10 | THR A 925ILE A1164GLY A 928GLY B 928ILE B1164 | 1.46A | 22.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N49_B_RITB301_1 (PROTEASE) | Ritonavir | 4 / 7 | GLY B1148ILE B1150ALA B 954ILE B 955 | 1.04A | 22.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS7_B_ACTB861_0 (NITRIC-OXIDESYNTHASE, BRAIN) | Acetic acid | 4 / 6 | GLY B 928ILE B1164GLN B1161SER B 924 | 1.70A | 17.11 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HKK_A_ALEA300_1 (CARBONIC ANHYDRASE 2) | Epinephrine | 4 / 6 | ASN A1173ILE A 916GLN A 917THR B 943 | 1.68A | 21.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GZ9_A_TXCA501_0 (PEPTIDE ABCTRANSPORTER PERMEASE) | Valaciclovir | 5 / 10 | VAL B 934ASN B 937ALA B 938GLN A 917ASN A1175 | 1.71A | 14.61 | CL B 3 ( 4.2A)NoneNoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EJG_D_NCTD501_1 (CYTOCHROME P450 2A13) | Nicotine | 4 / 6 | ASN A 937ALA A 940THR A 943LEU B1178 | 1.30A | 15.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TWD_C_377C401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) | Memantine | 4 / 6 | ASN B 907GLU B 900TYR B 899LEU B1181 | 1.42A | 19.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R30_A_SAMA501_0 (BIOTIN SYNTHASE) | S-Adenosylmethionine | 5 / 12 | THR B 925GLY B 928ASN B1168ASP B1165VAL A1158 | 1.46A | 18.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEU_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 7 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.08A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_A_CCSA47_0 (GLUTATHIONES-TRANSFERASE) | Carbocisteine | 4 / 7 | LEU A1167THR A 923LEU A 930GLY A 928 | 1.22A | 19.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYT_A_OBNA1104_1 (SODIUM/POTASSIUM-TRANSPORTING ATPASESUBUNIT ALPHA-1) | Ouabain | 5 / 12 | GLN B1161GLY A 928ALA A 926THR A 921ARG A1166 | 1.31A | 10.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2PIW_A_T3A932_1 (ANDROGEN RECEPTOR) | Liothyronine | 4 / 6 | LEU B 941VAL B 945LYS B 946ILE B1153 | 1.27A | 22.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKX_B_STRB601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) | Progesterone | 4 / 5 | ILE B 916LEU B1174GLU B 918VAL A 933 | 1.48A | 16.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVX_B_DIFB125_1 (TRANSTHYRETIN) | Diclofenac | 4 / 7 | LEU A 930LEU A 927SER A 924THR A 922 | 1.27A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVX_B_DIFB125_2 (TRANSTHYRETIN) | Diclofenac | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.59A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y0X_X_T44X500_2 (THYROID HORMONERECEPTOR BETA-1) | Levothyroxine | 4 / 5 | ILE B1164SER B 919LEU B1167ASN B1168 | 1.35A | 21.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7P_A_SALA1000_1 (LYSR-TYPE REGULATORYPROTEIN) | Salicylic acid | 5 / 10 | THR B 925ILE B1164GLY B 928GLY A 928ILE A1164 | 1.44A | 22.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DTJ_B_THRB402_0 (ASPARTOKINASE) | L-Threonine | 5 / 9 | ILE A1164ILE B1164ASP B1165GLY A 928GLN B1161 | 1.70A | 25.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AG0_A_ACRA608_0 (ALPHA-AMYLASE) | Acarbose | 4 / 6 | GLY A 892THR A 894GLN A 895TYR A1187 | 1.48A | 14.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E0F_A_RBFA301_1 (RIBOFLAVIN SYNTHASESUBUNIT ALPHA) | Riboflavin | 5 / 11 | SER B 924VAL B1170LEU B 920THR B 921GLU B1176 | 1.64A | 20.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E7C_A_HLTA4007_1 (SERUM ALBUMIN) | Halothane | 4 / 8 | LEU A 959ASP A 967LEU A 966LEU A 963 | 1.45A | 13.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EL5_B_1UNB201_2 (PROTEASE) | Nelfinavir | 6 / 12 | ASP A 932GLY A 928ASP B1165GLY B 928THR B 923THR B 922 | 1.73A | 18.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_E_SVRE510_2 (PHOSPHOLIPASE A2) | Suramin | 4 / 6 | LYS A 946GLN A 947GLY A 953LEU A1147 | 1.40A | 20.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVX_B_DIFB125_1 (TRANSTHYRETIN) | Diclofenac | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.61A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7W_A_SALA1300_1 (LYSR-TYPE REGULATORYPROTEIN) | Salicylic acid | 5 / 9 | THR B 925ILE B1164GLY B 928GLY A 928ILE A1164 | 1.39A | 21.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_J_ZOLJ401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) | Zoledronic acid | 4 / 6 | LEU B 927ASP B 932GLN B 931GLN A1161 | 1.62A | 20.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SU9_A_ACTA426_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) | Acetic acid | 3 / 3 | GLN A 939GLU B1169LYS B1172 | 1.25A | 17.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C12_F_SPMF1433_1 (NITROALKANE OXIDASE) | Spermine | 5 / 11 | GLU B 970VAL B 969ALA B 971SER B 964LEU B 966 | 1.67A | 17.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0S_A_ADNA500_1 (AURORA KINASE A) | Adenosine | 5 / 11 | LEU B 927GLY B 928LEU B 920LEU B1167ASP A 932 | 1.43A | 21.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_G_KANG301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.15A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_P_TRPP1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) | L-Tryptophan | 4 / 7 | GLY B 953ASP B1149ILE B1150GLN B 947 | 1.29A | 20.63 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5D_B_SAMB303_1 (METHYLTRANSFERASE) | S-Adenosylmethionine | 4 / 7 | SER A 924GLU A 918ASP B 932ASN B 937 | 1.57A | 22.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5F_N_BO2N201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) | Bortezomib | 5 / 11 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.27A | 22.7824.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NED_A_PFNA709_1 (LACTOTRANSFERRIN) | Fenoprofen | 4 / 6 | VAL B1170SER B 919ALA B 912PHE B 909 | 1.74A | 18.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I89_A_1FLA201_1 (TRANSTHYRETIN) | Diflunisal | 5 / 6 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.80A | 23.94 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_G_KANG301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 7 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.11A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYR_B_SVRB401_2 (NAD-DEPENDENTDEACETYLASESIRTUIN-5) | Suramin | 4 / 6 | GLN A 947ASN A 951ASN A1154LEU A 941 | 1.30A | 17.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZK_B_T44B128_1 (TRANSTHYRETIN) | Levothyroxine | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.75A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KBW_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) | Riboflavin | 5 / 12 | GLU B1169ASN A 935ALA A1155ASN A1154ASN A 942 | 1.67A | 21.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NNA_A_BZMA301_0 (ISATIN HYDROLASE A) | Benzyl Benzoate | 5 / 12 | LEU B 948SER B 956GLY B1148ASP B1149GLY B 953 | 1.55A | 21.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WVD_A_IVMA505_0 (BILE ACID RECEPTOR) | Ivermectin | 5 / 11 | GLU B1169ASN B1168ASN A 937ILE B 913LEU B1167 | 1.79A | 20.19 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N09_C_ADNC401_2 (ADENOSINE KINASE) | Adenosine | 4 / 5 | ASN B 910LEU B1178SER B 914ASN A 937 | 1.66A | 19.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVY_N_BO2N201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) | Bortezomib | 5 / 11 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.28A | 22.7824.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BWM_A_SAMA301_1 (CATECHOLO-METHYLTRANSFERASE) | S-Adenosylmethionine | 3 / 3 | SER A 924GLU A 918ASP B 932 | 1.23A | 22.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7K_A_SALA1302_1 (LYSR-TYPE REGULATORYPROTEIN) | Salicylic acid | 5 / 11 | THR B 925ILE B1164GLY B 928GLY A 928ILE A1164 | 1.47A | 22.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CFQ_B_DIFB1_1 (TRANSTHYRETIN) | Diclofenac | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.79A | 22.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VOO_B_C2FB702_1 (5-METHYLTETRAHYDROFOLATE HOMOCYSTEINES-METHYLTRANSFERASE) | Levomefolic acid | 4 / 5 | ASP A 932ASN B1168ASP B1165ASN A1159 | 1.63A | 18.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HYY_A_STIA600_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) | Imatinib | 5 / 12 | VAL B1157GLU A1176ILE A 913GLY B 928ALA A1171 | 1.27A | 20.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_J_KANJ301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 6 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.16A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PWJ_B_30ZB201_1 (TRANSTHYRETIN) | Masoprocol | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.75A | 19.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C12_B_SPMB1433_1 (NITROALKANE OXIDASE) | Spermine | 5 / 11 | GLU A 970VAL A 969ALA A 971SER A 964LEU A 966 | 1.67A | 17.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEU_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.15A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DWN_A_AQ4A602_0 (CYTOCHROME P450 1A1) | Erlotinib | 5 / 12 | SER B1151ASN B 951ASP B1149GLY B1148ILE B1153 | 1.55A | 14.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) | Ponatinib | 5 / 12 | LEU A1167ILE A1164LEU A 927LEU A 930ALA A 926 | 1.31A | 18.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MZ9_D_VDYD1001_5 (CARTILAGE OLIGOMERICMATRIX PROTEIN) | Calcidiol | 3 / 3 | THR A 923LEU A 920VAL A1170 | 0.96A | 15.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TZ8_C_DESC129_1 (TRANSTHYRETIN) | Diethylstilbestrol | 4 / 6 | LEU A 944ALA A 940LEU A 941SER A1156 | 1.38A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AIA_A_SAMA206_0 (UPF0217 PROTEINMJ1640) | S-Adenosylmethionine | 4 / 6 | LEU A 959GLY A 953LEU A 963SER A 964 | 1.33A | 20.09 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F16_2_BO221405_1 (PROTEASOME COMPONENTPRE3) | Bortezomib | 5 / 11 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.28A | 24.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VM8_B_SAMB301_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) | S-Adenosylmethionine | 5 / 10 | GLY B 928LEU A 930ILE A1164LEU A 927ALA A 926 | 1.18A | 23.11 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_F_CCSF47_0 (GLUTATHIONES-TRANSFERASE) | Carbocisteine | 4 / 5 | LEU A1184GLY A1185LYS A 903TYR A 899 | 1.67A | 19.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SUG_A_SUEA1201_1 (NS3 PROTEASE, NS4APROTEIN) | Grazoprevir | 5 / 12 | GLY A 928VAL A 934ASP A 932GLY B 928THR B 921 | 1.47A | 23.08 | None CL A 2 ( 4.1A)NoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XYT_F_TC9F1206_1 (SOLUBLEACETYLCHOLINERECEPTOR) | Tubocurarine | 5 / 12 | TYR A1187GLU A1188TYR A 899GLN A 904ILE A 905 | 1.48A | 20.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZTH_A_SAMA305_1 (CATECHOLO-METHYLTRANSFERASE) | S-Adenosylmethionine | 3 / 3 | SER A 924GLU A 918ASP B 932 | 1.11A | 24.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRANSPORTING ATPASESUBUNIT ALPHA-1) | Digoxin | 5 / 12 | GLN A1161ASP A 932GLY B 928ALA B 926ARG B1166 | 1.21A | 10.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BXM_A_SAMA402_0 (DIPHTHAMIDEBIOSYNTHESIS ENZYMEDPH2) | S-Adenosylmethionine | 5 / 12 | LEU B1184GLY B1185SER A 950LEU A 948ILE A 955 | 1.50A | 18.87 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ROX_B_T44B128_1 (TRANSTHYRETIN) | Levothyroxine | 4 / 6 | LEU A 930ALA A 926LEU A 927THR A 922 | 1.38A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SU9_A_ACTA426_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) | Acetic acid | 3 / 3 | GLN B 939GLU A1169LYS A1172 | 1.22A | 17.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKL_B_SUZB201_1 (TRANSTHYRETIN) | Sulindac | 4 / 8 | SER A1156LEU A 944ALA A 940LEU A 941 | 1.23A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GNG_B_QPSB601_3 (-) | Acarbose | 3 / 3 | ASP B1165ASP B 932ASN A1175 | 0.71A | 12.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_L_TRPL81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) | L-Tryptophan | 5 / 9 | VAL B 945GLY B1152ALA B1155ILE B1153SER B1156 | 1.70A | 21.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BYO_A_LNLA1216_1 (LIPOPROTEIN LPPX) | Alpha-Linolenic Acid | 4 / 5 | LEU B 959ILE B 962LEU B 966SER B 964 | 1.33A | 25.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_B_TFPB202_1 (PROTEIN S100-A4) | Trifluoperazine | 3 / 3 | GLU A1183LEU A1181ASP A1180 | 1.00A | 21.85 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HA2_A_SWFA3001_1 (SERUM ALBUMIN) | Warfarin | 6 / 11 | ALA B 940LEU B 941LEU B 944LEU B 948SER B 949ILE B1150 | 1.71A | 13.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | Roflumilast | 3 / 3 | ASP B1180LEU B1178GLN A 939 | 1.33A | 19.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKK_A_SUZA201_1 (TRANSTHYRETIN) | Sulindac | 4 / 8 | LEU A 944ALA A 940LEU A 941SER A1156 | 1.22A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VOO_A_C2FA3001_1 (5-METHYLTETRAHYDROFOLATE HOMOCYSTEINES-METHYLTRANSFERASE) | Levomefolic acid | 4 / 5 | ASP A 932ASN B1168ASP B1165ASN A1159 | 1.62A | 18.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKJ_B_SUZB201_1 (TRANSTHYRETIN) | Sulindac | 4 / 8 | SER A1156LEU A 944ALA A 940LEU A 941 | 1.18A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MG0_2_BO221405_1 (PROTEASOME COMPONENTPRE3PROTEASOME COMPONENTPUP1) | Bortezomib | 5 / 12 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.23A | 24.2721.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EUP_A_ASDA452_1 (CYTOCHROME P450ERYF) | 4-Androstenedione | 5 / 8 | PHE A 952SER A 956ILE A 955LEU A 959LEU A1147 | 1.74A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6D8P_A_ACTA814_0 (UNCHARACTERIZEDPROTEIN) | Acetic acid | 4 / 5 | GLN B 936ASN A1168THR A 921LEU A 920 | 1.36A | 11.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEV_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 7 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.18A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EM0_B_CHDB500_0 (ILEAL BILEACID-BINDING PROTEIN) | Cholic Acid | 4 / 7 | THR A 922GLU A 918SER A 914THR A 921 | 1.32A | 21.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ICT_D_T44D129_2 (TRANSTHYRETIN) | Levothyroxine | 4 / 7 | LEU A 930LEU A 927SER A 924THR A 922 | 1.36A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NNH_A_9CRA502_1 (CYTOCHROME P450 2C8) | Alitretinoin | 5 / 12 | ILE A 913SER A 914ILE A 916LEU A1174ASN A1173 | 1.23A | 17.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BOJ_A_4TXA201_1 (TRANSTHYRETIN) | Gemfibrozil | 5 / 6 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.76A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XUD_A_SAMA303_1 (CATECHOLO-METHYLTRANSFERASE) | S-Adenosylmethionine | 3 / 3 | SER B 924GLU B 918ASP A 932 | 1.21A | 22.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B9L_A_AZZA1010_1 (SERUM ALBUMIN) | Zidovudine | 4 / 8 | LEU B 927ILE B1164GLY A 928LYS A 929 | 1.29A | 13.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M93_B_ACTB303_0 (S25-26 FAB (IGG1K)HEAVY CHAINS25-26 FAB (IGG1K)LIGHT CHAIN) | Acetic acid | 4 / 5 | GLY A 953SER A 950ALA A 954PHE A 952 | 1.57A | 18.6720.85 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KAW_A_SUZA91_1 (SEGMENT POLARITYPROTEIN DISHEVELLEDHOMOLOG DVL-1) | Sulindac | 5 / 11 | LEU B 948ILE B1150SER B1151ILE B1153LEU B 941 | 1.28A | 21.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PCL_B_SAMB301_1 (O-METHYLTRANSFERASEFAMILY PROTEIN) | S-Adenosylmethionine | 4 / 4 | SER B 924GLU B1169GLU B1176ASP A 932 | 1.47A | 20.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MSS_B_STIB1_1 (TYROSINE-PROTEINKINASE ABL1) | Imatinib | 5 / 12 | VAL B1157GLU A1176ILE A 913GLY B 928ALA A1171 | 1.30A | 21.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IEP_B_STIB202_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL) | Imatinib | 5 / 12 | VAL B1157GLU A1176ILE A 913GLY B 928ALA A1171 | 1.23A | 21.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PCL_A_SAMA301_1 (O-METHYLTRANSFERASEFAMILY PROTEIN) | S-Adenosylmethionine | 4 / 5 | SER B 924GLU B 918ASP A 932ASN A 937 | 1.62A | 20.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_C_CCSC47_0 (GLUTATHIONES-TRANSFERASE) | Carbocisteine | 4 / 6 | LEU A1184GLY A1185LYS A 903TYR A 899 | 1.67A | 19.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ROZ_A_NCAA266_0 (APOLIPOPROTEINA-I-BINDING PROTEIN) | Nicotinamide | 4 / 6 | ASP B1180LEU B1178LEU A 944THR A 943 | 1.29A | 21.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OJ4_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Diclofenac | 4 / 8 | LEU A 941LEU A 944VAL A 945ILE A1150 | 1.02A | 20.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Tretinoin | 5 / 12 | ILE B1179ALA B 906GLN B 908ILE B 913PHE B 909 | 1.28A | 18.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XOY_A_DX4A401_0 (MITOGEN-ACTIVATEDPROTEIN KINASE 1) | Tioguanine | 4 / 6 | ALA A 940GLN A 939LEU A 944LEU B1178 | 1.66A | 18.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I41_A_MIXA501_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) | Mitoxantrone | 5 / 12 | ASP B 932THR A 923ASP A1165ILE A1164GLU A1163 | 1.76A | 18.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KMD_C_6UBC1304_1 (ION TRANSPORTPROTEIN) | Amlodipine | 4 / 5 | ILE B1153LEU B1147GLY B1148PHE B 952 | 1.30A | 22.63 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BOJ_B_4TXB201_1 (TRANSTHYRETIN) | Gemfibrozil | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.77A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEX_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 7 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.09A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_B_SVRB501_2 (PHOSPHOLIPASE A2) | Suramin | 5 / 11 | LEU B1147GLY B1148ILE B1150SER B 949SER B 950 | 1.43A | 20.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5Z_N_BO2N201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) | Bortezomib | 5 / 12 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.28A | 22.7824.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZTH_A_SAMA305_1 (CATECHOLO-METHYLTRANSFERASE) | S-Adenosylmethionine | 3 / 3 | SER B 924GLU B 918ASP A 932 | 1.13A | 24.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MSD_A_BEZA1202_0 (CARBOXYLIC ACIDREDUCTASE) | Benzoic Acid | 4 / 5 | ILE A 916PHE A 909SER A1177ALA A 912 | 1.70A | 8.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_B_CCSB47_0 (GLUTATHIONES-TRANSFERASE) | Carbocisteine | 4 / 7 | LEU A1167THR A 923LEU A 930GLY A 928 | 1.13A | 19.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NNH_B_9CRB502_1 (CYTOCHROME P450 2C8) | Alitretinoin | 5 / 10 | SER B 924ILE B1160ASN B1159ASN B1168ILE A1164 | 1.43A | 17.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVY_B_BO2B201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) | Bortezomib | 5 / 11 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.27A | 22.7824.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I1N_F_DVAF9_0 (D-VILLIN HEADPIECESUBDOMAINVILLIN-1) | L-Valine | 3 / 3 | ALA B 940ASN B 942LEU B 944 | 1.30A | 12.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IK7_B_IMNB201_1 (TRANSTHYRETIN) | Indomethacin | 5 / 8 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.75A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEY_C_SAMC300_1 (PUTATIVE RRNAMETHYLASE) | S-Adenosylmethionine | 3 / 3 | ASN A1173ASP B 932GLN B 931 | 1.04A | 19.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D2T_A_1FLA502_1 (TRANSTHYRETIN) | Diflunisal | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.76A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.13A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.10A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERS_A_ACTA803_0 (GEPHYRIN) | Acetic acid | 3 / 3 | THR A 921ALA A1171ASN A1168 | 1.51A | 17.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 7 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.18A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FOF_F_MFXF0_1 (DNA TOPOISOMERASE 4SUBUNIT A) | Moxifloxacin | 2 / 3 | GLY A 928SER A 924 | 0.45A | 14.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_E_TRPE1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) | L-Tryptophan | 4 / 7 | GLY B 953ASP B1149ILE B1150GLN B 947 | 1.21A | 20.63 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.12A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_A_SAMA602_1 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) | S-Adenosylmethionine | 3 / 3 | ASP A 932ASN A 937SER B 919 | 1.33A | 20.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MZ9_D_VDYD1001_2 (CARTILAGE OLIGOMERICMATRIX PROTEIN) | Calcidiol | 3 / 3 | LEU A1167VAL A1170LEU A1174 | 0.67A | 15.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V0Z_O_C41O1327_1 (RENIN) | Aliskiren | 5 / 12 | GLN A 939GLY A 928VAL A1158ASP A 932ILE B1164 | 1.43A | 22.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2PIW_A_T3A932_1 (ANDROGEN RECEPTOR) | Liothyronine | 4 / 6 | LEU A 941VAL A 945LYS A 946ILE A1153 | 1.27A | 22.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MG0_N_BO2N1404_1 (PROTEASOME COMPONENTPRE3) | Bortezomib | 5 / 11 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.25A | 24.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVY_B_BO2B201_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-1) | Bortezomib | 5 / 11 | THR A 921THR A 922THR A 923SER A 914ALA A1171 | 1.28A | 22.7824.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E4D_B_BEZB201_0 (HYDROXYNITRILE LYASE) | Benzoic Acid | 5 / 11 | VAL A 933VAL A 934ILE A1164ILE A1160LEU A 930 | 1.51A | 22.71 | None CL A 2 ( 4.1A)NoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVX_B_DIFB125_1 (TRANSTHYRETIN) | Diclofenac | 4 / 7 | LEU B 930LEU B 927SER B 924THR B 922 | 1.32A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C12_D_SPMD1434_1 (NITROALKANE OXIDASE) | Spermine | 5 / 10 | GLU A 970VAL A 969ALA A 971SER A 964LEU A 966 | 1.67A | 17.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2PKM_A_ADNA501_1 (ADENOSINE KINASE) | Adenosine | 5 / 12 | ALA B 954GLY B 953GLN B 947GLY B1148ASP B1149 | 1.35A | 21.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_K_KANK301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.14A | 21.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G24_A_ACAA1004_1 (PENTATRICOPEPTIDEREPEAT-CONTAININGPROTEIN AT2G32230,MITOCHONDRIAL) | Aminocaproic Acid | 4 / 6 | ALA A 940ASN A 942LEU A 944VAL A 945 | 1.40A | 16.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKJ_A_SUZA201_1 (TRANSTHYRETIN) | Sulindac | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.76A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRANSPORTING ATPASESUBUNIT ALPHA-1) | Digoxin | 5 / 12 | GLN A1161ASP A 932GLY B 928ALA B 926ARG B1166 | 1.21A | 10.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LF3_N_BO2N304_1 (PROTEASOME SUBUNITBETA TYPE-6) | Bortezomib | 5 / 12 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.28A | 22.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_C_CVIC301_1 (REGULATORY PROTEINTETR) | Gentian Violet | 4 / 7 | GLN A 908ILE A1179GLN A1182ASP A1180 | 1.53A | 22.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KC4_E_RBFE201_2 (RIBOFLAVINTRANSPORTER RIBU) | Riboflavin | 3 / 3 | LYS B1172ASP A 932ILE B 913 | 1.63A | 21.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N4F_A_ASRA141_0 (LYSOZYME C) | Arsanilic acid | 4 / 6 | ASN B1168GLY A 928THR B 925SER B 924 | 1.62A | 21.43 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7B_A_TCWA1126_1 (TRANSTHYRETIN) | Tolcapone | 5 / 6 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.72A | 23.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YZQ_A_SAMA6075_0 (PUTATIVEUNCHARACTERIZEDPROTEIN PH1780) | S-Adenosylmethionine | 5 / 12 | THR A 925VAL B1158ILE B1160ILE B1164GLN B1161 | 1.69A | 19.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Tretinoin | 5 / 12 | ALA B 938GLN B 939ASN A1168ILE B1160LEU B 930 | 1.18A | 18.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7U_A_FVTA501_0 (PEPTIDE ABCTRANSPORTER PERMEASE) | Aminolevulinic acid | 4 / 6 | VAL A1157ASN A 935ASN B1173GLU B1169 | 1.61A | 14.61 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_D_MIXD3539_2 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) | Mitoxantrone | 3 / 3 | VAL A 934VAL A1157ASP A1165 | 1.08A | 19.80 | CL A 2 ( 4.1A)NoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XUD_A_SAMA303_1 (CATECHOLO-METHYLTRANSFERASE) | S-Adenosylmethionine | 3 / 3 | SER A 924GLU A 918ASP B 932 | 1.20A | 22.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N23_A_OBNA1_1 (SODIUM/POTASSIUM-TRANSPORTING ATPASESUBUNIT ALPHA-1) | Ouabain | 5 / 11 | GLN A 931ASP B1165ASN B1168ILE B1160ARG A1166 | 1.75A | 11.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7B_B_TCWB1126_1 (TRANSTHYRETIN) | Tolcapone | 5 / 7 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.68A | 23.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BWY_A_SAMA301_1 (COMT PROTEIN) | S-Adenosylmethionine | 3 / 3 | SER A 924GLU A 918ASP B 932 | 1.16A | 22.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CDQ_B_SAMB1500_0 (ASPARTOKINASE) | S-Adenosylmethionine | 4 / 7 | SER B 949ASP B1149SER B 957LEU B1147 | 1.59A | 14.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) | Naproxen | 5 / 9 | ALA B 940ALA B 938LEU B 941LEU B 944VAL B 945 | 1.67A | 13.51 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZK_A_T44A128_1 (TRANSTHYRETIN) | Levothyroxine | 5 / 9 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.74A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ELZ_B_CHDB150_0 (ILEAL BILEACID-BINDING PROTEIN) | Cholic Acid | 5 / 11 | THR A 943VAL B1170LEU B 920GLN A 936THR B 921 | 1.78A | 21.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TYR_A_9CRA131_1 (TRANSTHYRETIN) | Alitretinoin | 5 / 6 | LEU A 930ALA A 926LEU A 927SER A 924THR A 922 | 1.63A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1Y_A_RBFA1176_1 (PUTATIVE PROTEASE I) | Riboflavin | 4 / 8 | GLN A 917ASN A1173GLN B 936ASN B 937 | 1.77A | 20.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VOO_F_C2FF3001_1 (5-METHYLTETRAHYDROFOLATE HOMOCYSTEINES-METHYLTRANSFERASE) | Levomefolic acid | 4 / 4 | ASP A 932ASN B1168ASP B1165ASN A1159 | 1.60A | 18.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PP1_A_ACTA590_0 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) | Acetic acid | 4 / 5 | GLU A1163LEU A 927GLN A1161GLY A 928 | 1.45A | 20.43 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LF7_B_6V8B304_0 (PROTEASOME SUBUNITBETA TYPE-6PROTEASOME SUBUNITBETA TYPE-7) | Ixazomib | 5 / 12 | THR B 921THR B 922THR B 923SER B 914ALA B1171 | 1.32A | 22.7722.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7K_D_SALD1300_1 (LYSR-TYPE REGULATORYPROTEIN) | Salicylic acid | 5 / 12 | THR B 925ILE B1164GLY B 928GLY A 928ILE A1164 | 1.42A | 22.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEU_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) | Kanamycin | 4 / 8 | ASP B1165ASP B 932ASN B1159GLU B1163 | 1.13A | 21.32 | None |